69 related articles for article (PubMed ID: 8314533)
21. A phase I trial of intravenous melphalan, paclitaxel, and cisplatin plus granulocyte-colony stimulating factor in patients with suboptimal advanced epithelial ovarian carcinoma or peritoneal carcinoma.
Gershenson DM; Morris M; Burke TW; Levenback C; Wolf J; Lee JJ; Thall PF; Atkinson EN; Silva EG; Wharton JT
Cancer; 1999 Dec; 86(11):2291-300. PubMed ID: 10590370
[TBL] [Abstract][Full Text] [Related]
22. Phase I trial of cisplatin in combination with glutathione.
Plaxe S; Freddo J; Kim S; Kirmani S; McClay E; Christen R; Braly P; Howell S
Gynecol Oncol; 1994 Oct; 55(1):82-6. PubMed ID: 7959273
[TBL] [Abstract][Full Text] [Related]
23. Phase I study of a biweekly schedule of a fixed dose of cisplatin with increasing doses of paclitaxel in patients with advanced oesophageal cancer.
van der Gaast A; Kok TC; Kerkhofs L; Siersema PD; Tilanus HW; Splinter TA
Br J Cancer; 1999 Jun; 80(7):1052-7. PubMed ID: 10362115
[TBL] [Abstract][Full Text] [Related]
24. Phase II trial of intraperitoneal cisplatin with intravenous doxorubicin and cyclophosphamide in previously untreated patients with advanced ovarian cancer-long-term follow-up.
Morgan RJ; Braly P; Cecchi G; Leong L; Shibata S; Margolin K; Somlo G; McNamara M; Longmate J; Schinke S; Raschko J; Nagasawa S; Kogut N; Parker P; Stein A; Cho J; Smith E; Coluzzi P; Najera L; Johnson D; Womack E; Doroshow JH
Gynecol Oncol; 1999 Dec; 75(3):419-26. PubMed ID: 10600300
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of an intraperitoneal chemotherapy program implemented at the Princess Margaret Hospital for patients with epithelial ovarian carcinoma.
Chin SN; Pinto V; Rosen B; Oza A; Dodge J; Murphy J; Mackay H
Gynecol Oncol; 2009 Mar; 112(3):450-4. PubMed ID: 19135709
[TBL] [Abstract][Full Text] [Related]
26. Intraperitoneal high-dose cisplatin and etoposide with systemic thiosulfate protection in second-line treatment of advanced ovarian cancer.
Malmström H; Rasmussen S; Simonsen E
Gynecol Oncol; 1993 May; 49(2):166-71. PubMed ID: 8504983
[TBL] [Abstract][Full Text] [Related]
27. Dose intensification of cisplatin chemotherapy through biweekly administration.
Kim S; Howell SB; McClay E; Kirmani S; Goel R; Plaxe S; Braly P; Bonetti A
Ann Oncol; 1993 Mar; 4(3):221-7. PubMed ID: 8471554
[TBL] [Abstract][Full Text] [Related]
28. Prospective trial of ifosfamide, paclitaxel, and cisplatin in patients with advanced non-transitional cell carcinoma of the urothelial tract.
Galsky MD; Iasonos A; Mironov S; Scattergood J; Donat SM; Bochner BH; Herr HW; Russo P; Boyle MG; Bajorin DF
Urology; 2007 Feb; 69(2):255-9. PubMed ID: 17320659
[TBL] [Abstract][Full Text] [Related]
29. Vinorelbine and cisplatin (CIVIC regimen) for the treatment of metastatic breast carcinoma after failure of anthracycline- and/or paclitaxel-containing regimens.
Ray-Coquard I; Biron P; Bachelot T; Guastalla JP; Catimel G; Merrouche Y; Droz JP; Chauvin F; Blay JY
Cancer; 1998 Jan; 82(1):134-40. PubMed ID: 9428489
[TBL] [Abstract][Full Text] [Related]
30. Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: preliminary results.
Belli L; LeChevalier T; Gottfried M; Adams D; Ruffie P; LeCesne A; Tete L; Pellae-Cosset B
Semin Oncol; 1995 Dec; 22(6 Suppl 15):29-33. PubMed ID: 8643967
[TBL] [Abstract][Full Text] [Related]
31. Infusional 5-fluorouracil/leucovorin plus paclitaxel and cisplatin in the first-line treatment of metastatic breast cancer: results of a phase II study.
Klaassen U; Wilke H; Müller C; Borquez D; Harstrick A; Seeber S
Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-58-S17-60. PubMed ID: 9374095
[TBL] [Abstract][Full Text] [Related]
32. Phase I and pharmacologic study of a 3-hour infusion of paclitaxel followed by cisplatinum and 5-fluorouracil in patients with advanced solid tumors.
Bhalla KN; Kumar GN; Walle UK; Ibrado AM; Javed T; Stuart RK; Reed C; Arbuck SG; Walle T
Clin Cancer Res; 1999 Jul; 5(7):1723-30. PubMed ID: 10430075
[TBL] [Abstract][Full Text] [Related]
33. A phase I study of cisplatin, etoposide, and paclitaxel in small cell lung cancer.
Bunn PA; Kelly K
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-144-S12-148. PubMed ID: 9331140
[TBL] [Abstract][Full Text] [Related]
34. Intraperitoneal cisplatin and intravenous paclitaxel in the treatment of epithelial ovarian cancer patients with a positive second look.
Makhija S; Sabbatini P; Aghajanian C; Venkatraman E; Spriggs DR; Barakat R
Gynecol Oncol; 2000 Oct; 79(1):28-32. PubMed ID: 11006026
[TBL] [Abstract][Full Text] [Related]
35. [Double channel chemotherapy with intra-arterial infusion of DDP and concurrent intra-venous infusion of sodium thiosulfate (STS) in bladder cancer].
Sekine H; Fukui I; Yamada T; Igarashi K; Yokokawa M; Yosida T
Hinyokika Kiyo; 1986 Jan; 32(1):43-8. PubMed ID: 3962808
[TBL] [Abstract][Full Text] [Related]
36. Clinical and pharmacokinetic study of intraperitoneal cisplatin at two dose levels: 100 mg/m2 alone or 200 mg/m2 with i.v. sodium thiosulfate.
Canal P; de Forni M; Chatelut E; Chevreau C; Johnson NP; Houin G; Bugat R
Acta Med Austriaca; 1989; 16(3-4):84-6. PubMed ID: 2609919
[TBL] [Abstract][Full Text] [Related]
37. Intraperitoneal cis-diamminedichloroplatinum with systemic thiosulfate protection.
Howell SB; Pfeifle CE; Wung WE; Olshen RA
Cancer Res; 1983 Mar; 43(3):1426-31. PubMed ID: 6681730
[TBL] [Abstract][Full Text] [Related]
38. [Intraperitoneal and intrapleural two channel chemotherapy by cisplatinum (DDP) and sodium thiosulfate for the treatment of ovarian cancer].
Hatae M; Tezuka H; Ushiki N; Ezono Y; Igyuin H; Terahara M; Hokanishi H
Gan To Kagaku Ryoho; 1984 Mar; 11(3):433-9. PubMed ID: 6538403
[TBL] [Abstract][Full Text] [Related]
39. [Systemic chemotherapy with super-high dose cisplatin and sodium thiosulfate (STS) rescue in mice].
Lee K; Sawamura M; Kubota T; Ishibashi N; Kawamura E
Gan To Kagaku Ryoho; 1985 Apr; 12(4):875-9. PubMed ID: 4039124
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness of "two-route chemotherapy" using cisplatin and its antidote, sodium thiosulfate, on lifespan of rats bearing metastatic liver tumors.
Uozumi J; Sagiyama K; Aoki K; Iwamoto Y; Baba T
Cancer Treat Rep; 1983 Dec; 67(12):1067-74. PubMed ID: 6686083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
